✘ NOT COMPLIANT
Advanced Medical Equipment & Technology | USA
Progenity Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.
The financials fail all the three standards we check against.
Total Analysts: 2
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
|Dividends per Share|
Progenity, Inc. is a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women’s health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier Test, Riscover Hereditary Cancer Test, and Resura Prenatal Test for Monogenic Disease. The Company is also developing its pipeline products, such as Preecludia pre-eclampsia rule-out test, Drug Delivery System (DDS) platform, and Oral Biopharmaceutical Delivery System (OBDS). It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders.
|✘ FTSE||✘ AAOIFI||✘ DJIM|
✘ NOT COMPLIANT
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.